Table 1.
Patient and disease characteristics
| All UAE patients (N=24) |
IV-to-PO switch (N=5) |
IV-only (N=19) |
|
|---|---|---|---|
| Age, mean ± SD | 50.2±16.1 | 54.2±16.3 | 49.1 ± 16.3 |
| Male, n (%) | 11 (45.8%) | 1 (20.0%) | 10 (52.6%) |
| Asian, n (%) | 22 (91.7%) | 3 (60.0%) | 19 (100.0%) |
| Charlson Comorbidity | 2.2±2.9 | 2.2±2.9 | 2.2±2.9 |
| Index, mean ± SD | |||
| Primary reason for hospitalization is treatment of MRSA cSSTI, n (%) | 16 (66.7%) | 4 (80.0%) | 12 (63.2%) |
| Timing of cSSTI diagnosis, n (%) | |||
| At hospital admission | 16 (66.7%) | 4 (80.0%) | 12 (63.2%) |
| 1–3 days after admission | 2 (8.3%) | 0 (0.0%) | 2 (10.5%) |
| 4+ days after admission | 6 (25.0%) | 1 (20.0%) | 5 (26.3%) |
| Type of cSSTI, n (%) | |||
| Surgical site infection | 10 (41.7%) | 2 (40.0%) | 8 (42.1%) |
| Major abscess | 12 (50.0%) | 3 (60.0%) | 9 (47.4%) |
| Deep/extensive cellulitis | 2 (8.3%) | 0 (0.0%) | 2 (10.5%) |
| cSSTI location, n (%) | |||
| Head/skull/neck | 3 (12.5%) | 0 (0.0%) | 3 (15.8%) |
| Torso/abdomen | 16 (66.7%) | 5 (100.0%) | 11 (57.9%) |
| Upper extremity | 1 (4.2%) | 0 (0.0%) | 1 (5.3%) |
| Lower extremity | 4 (16.7%) | 0 (0.0%) | 4 (21.1%) |
| Sepsis, severe sepsis, or septic shock during cSSTI episode, n (%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Abbreviations: cSSTI, complicated skin and soft tissue infection; IV, intravenous; MRSA, Methicillin-resistant Staphylococcus aureus; PO, oral; SD, standard deviation; UAE, United Arab Emirates.